UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

SCHEDULE TO

(RULE 14d-100)

 

Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934

 


 

Monsanto Company

(Name of Subject Company)

 


 

Bayer Aktiengesellschaft

(Names of Filing Person (Offeror))

 

Common Stock, $0.01 par value per share

(Title of Class of Securities)

 

61166W101

(CUSIP Number of Class of Securities)

 

Dr. Jan Heinemann

Bayer Aktiengesellschaft

BAG-LPC-MA

Kaiser-Wilhelm-Allee, Q26

51368 Leverkusen

Germany

(+49) 214 30-1

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of Filing Persons)

 


 

Copy to:

 

Matthew G. Hurd

Eric M. Krautheimer

Sullivan & Cromwell LLP

125 Broad Street

New York, NY 10004

(212) 558-4000

 


 

CALCULATION OF FILING FEE

 

Transaction Valuation

 

Amount of Filing Fee

Not applicable

 

Not applicable

 

x

Pursuant to General Instruction D to Schedule TO, no filing fee is required in connection with this filing as it contains only preliminary communications made before the commencement of a tender offer.

 

 

o

Check the box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

 

 

 

 

 

 

Amount Previously Paid:

 

Not applicable

 

Filing Party:

 

Not applicable

Form or Registration No.:

 

Not applicable

 

Date Filed:

 

Not applicable

 

x

Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

 

Check the appropriate boxes below to designate any transactions to which the statement relates:

 

 

x

third-party tender offer subject to Rule 14d-1.

 

o

issuer tender offer subject to Rule 13e-4.

 

o

going-private transaction subject to Rule 13e-3.

 

o

amendment to Schedule 13D under Rule 13d-2.

 

 

 

Check the following box if the filing is a final amendment reporting the results of the tender offer:  o

 

 

If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:

 

 

 

 

o

Rule 13e-4(i) (Cross-Border Issuer Tender Offer)

 

o

Rule 14d-1(d) (Cross-Border Third Party Tender Offer)

 

 

 



 

EXHIBIT INDEX

 

Exhibit 99.1          New Transaction Website FAQ Content

Exhibit 99.2          Letter to Bayer Animal Health Employees sent on May 26, 2016

Exhibit 99.3          Additional Q&A provided in response to individual inquiries.

 

2